Introduction
The acquired immune deficiency syndrome (AIDS) is characterized by immunosuppression which predisposes patients to opportunistic infections and certain unusual forms of neoplasms. This syndrome was first recognized as a clinical entity in 1981 (Gottlieb et aI., 1981; Masur et aI., 1981; Siegal et el., 1981) . In 1984, a human retrovirus, HIV-1, was found to be the cause of AIDS (Barre-Sinoussi et aI., 1983; Gallo et aI., 1984; Popovic et aI., 1984) . The human immunodeficiency virus (HIV-1) preferentially infects and destroys CD4-positive T-cells. After the discovery of the HIV-t, efforts were directed towards finding drugs which would be effective as anti-HIV agents. Several chemical agents, including interferon, have been tested for their therapeutic potential against HIV-1 (Ho et aI., 1985; McCormick et aI., 1985; Mitsuya et al., 1985; Narashima et al., 1986; Anand et aI., 1988) . The dideoxynucleoside analogue 3'-azido-2' ,3'-dideoxythymidine (AZl) was found to be very efficacious in inhibiting the infectivity and cytopathic effect of HIV-1 in vitro (Mitsuya et al., 1985; Mitsuya et al., 1987) .AZT has been shown to increase the survival and decrease the frequency of opportunistic infections in certain patients with AIDS and AIDS-related complex (ARC) (Yarchoan et al., 1988) .AZT, however, is associated with toxicities that limit its use, particularly bone marrow suppression with megaloblastic changes though the decline in CD4-positive cells has been delayed in patients who have been taking AZT for prolonged periods (Richman et aI., 1987; Yarchoan et al., 1988; Yarchoan et al., 1989) . In 1988, AZT-resistant strains of HIV were isolated from patients (Larder et aI., 1989) .Thus, there is a great need for alternative drugs and combination therapies.
Recently it was shown that dextran sulphate (OS) has anti-Hlv activity and acts synergistically with AZT (Ito et aI., 1989; Ueno and Kuno, 1987) . PPS, like OS, is a negatively charged polysaccharide but has a lower molecular weight (4000 for PPS; >6000 for OS). PPS has been reported to increase the number of circulating T-cells in a subset of migraine patients who have low basophil and J-cell concentration (Thonnard-Neuman and Neckers 1981; Thonnard-Neuman and Bigelow, 1988) . PPS haã lso been shown to have low anticoagulant activity (Soria et aI., 1980; Vinazzer et al., 1980; Baba et al., 1988) . In fact it has been reported that PPS achieves its anti-HIV-1 activity at a concentration 370-fold below its anticoagulant threshold (Baba et aI., 1988) . A-CDS and B-CDS are cyclical sulphated polysaccharides Pitha, 1989) whereas PPS is a sulphated polysaccharide with linear configuration (see Pentosan Polysulfate (SP-54) Basic Information, published by bene-Arzeneimittel GmbH, Munchen 71, Germany, March 1985, for background information). Encouraged by our preliminary observations and other reports of anti-HIV activity of PPS (Baba et aI., 1988; Bagasara and Lischner, 1988) we investigated and compared other sulphated sugars (A-CDS and B-CDS) with PPSand studied their synergism with AZT in normal human PMNCs. PMNCs provide a reasonable corollary to the in vivo condition for testing the anti-HIV activity of the drugs (Anand et al., 1988) . 
Results

Inhibitory effect of drugs on virus replication
The dose-response relationship of sulphated sugars, A-CDS, PPS and B-CDS, with the replication of HIV-1 was studied in PMNC cultures. Cultures were infected with virus and treated with the drugs simultaneously and were tested to evaluate the amount of virus production by the reverse transcriptase (R1) method. The dose-response relationship showed that A-CDS was more potent than PPS and B-CDS, though all drugs had significant anti-HIV activity ( Fig. 1 ). At concentrations of 1.0 f.Lg mr' or less, Table 1 . Direct effect of PPS on RT activity. Fig. 1 . Dose-response relationship of sulphated sugars as tested six days after exposure. PHA-PMNCs were exposed to A-CDS and PPS and infected with HIV-1 as follows. PMNCs stimulated with 10.0fL9 mr' of PHA were further propagated in Medium B (RPMI-1640 medium with 10% fetal calf serum, 10% T-cell growth factor, and 1:500 goat antibody to human interferon) at 10 6 cells rnr' in 20 ml and were exposed to different concentrations of drugs and simultaneously infected with 10000 c.p.m. rnr' of HIV-1 in 20mVcuiture flask. Cultures were tested for the quantity of cell-free virus in the culture supernatants using the RT method. RT activity in the disrupted virions was tested by using exogenous template poly (rA).(d1)'2-18 as described (Anand et al., 1988) . The reaction mixture consisted of 50mM Tris-hydrochloride (pH 7.5), 5mM dithiothreitol100mM KCI, 10mM MgCI2, 10fLM ["H]-TIP, Triton X-100 containing poly (rA).(d1)'2-'6 at 30 fLg ml-' (mcg rnr').The reaction mixture was incubated at 3rC for 2 hours. and ["H]-TIP incorporated into polymers was precipitated with 10% trichloroacetic acid, collected on a glass fibre filter. and counted in an LKB 1219 Rackbeta scintillation counter. Various cultures in the experiment are represented: 0-0. A-CDS; ...... PPS; 0-0. B-CDS. The values are means of two determinations tested in two separate experiments. The range of variation was no greater than 15%.
The direct effect of the drugs on RT activity was tested by treating detergent-disrupted HIV-1 (LAV-1SRu) with different concentrations of the drugs (B-CDS and A-CDS were ineffective, data not shown). RT activity in disrupted virions was tested by the use of exogenous template poly (rA).(d1)12-'8 as described in the Materials and Experimental procedures. RT c.p.m. values in control (drug-free) cultures were used as 0% inhibition value and the percent inhibition in drug-treated samples was calculated from this value. The values represent means of two determinations tested in two separate experiments. The difference between duplicates was no greater than 15%. 
o however, up to a three-fold increase in virus production was observed in the presence of PPS and B-CDS, but not A-CDS. Inhibition of virus replication was further substantiated by. using the p24 antigen enzyme-linked immunosorbent assay (ELISA). Intracellular changes in the amount of HIV-1 following exposure to PPS were studied by measuring p24 antigen in the supernatant-free lysed cells. PPSexposure resulted in a decrease in HIV-specific p24 in the cells concomitant with the virus suppression observed in the supernatants using the RT assay and p24 antigen data (not shown).
Inhibitory effect on reverse transcriptase activity
We next examined the direct effect of A-CDS, B-CDS and PPS on the reverse transcriptase enzyme activity by treating a detergent-disrupted LAV-1 SRu isolate with these drugs and subjecting it to the RT method. PPS inhibited the reaction to 87% at 4.0 /-1g mr' and over 90% at 5.0/-1g mr' (Table 1) . No inhibition, however, was observed with A-CDS and B-CDS at the concentrations tested (up to 25.0 fL9 ml"). With PPS there was an indication of enhancement ofthe reaction at 0.1 and 0.5 fL9 rnr'.
Lymphoproliferative effect
To understand the mechanism of virus enhancement and to evaluate the toxicity of the sulphated sugars to PMNCs in culture, cell viability counts were performed on trypanblue-stained cells. Sulphated sugars at concentrations up to 100 fL9 mr' were essentially nontoxic to PMNCs, whereas AZT, even at 10 nM, showed some toxicity (Table  2) . Sulphated sugars in combination experiments were also nontoxic and when used in combination with AZT actually reduced AZT~associated toxicity. The results demonstrated that the sulphated sugars, in addition, exhibited a Iymphoproliferative effect since an up to three-fold increase in cell numbers relative to the control cultures was observed, particularly at low drug concentrations. PPS exhibited more Iymphoproliferative activity than B-CDS and A-CDS (Table 2) . It was further observed that sulphated sugars (PPSmore than A-CDS and B-CDS) also had a protective effect on infected cells from HIVassociated cytopathic effect cultures relative to virusinfected drug-free cultures (data not shown). PHA-PMNCs were plated at 1 x 10 6 cells rnr' in 10ml volume in all cultures and exposed once to different concentrations of the drugs. After six days, aliquots from the cultures were taken and counts for viable cells were made using the trypan blue exclusion method. The numbers represent averages of two determinations and the difference between duplicates was no greater than 4.3 x 10 4 cells mr ' .The cultures were from the same batch of PMNCs and the experiment was repeated twice.
Sulphated sugar alpha-cyclodextrin sulphate 43 Synergistic interaction of A-CDS and AZT was tested by infecting PHA-PMNCs and exposing to drugs slmultaneously, Cell-free culture supernatants were tested using the RT method for virus replication after six days. The decrease in virus replication was calculated on the basis of activity in control drug-free culture. The values represent means of two determinations from two different experiments and the difference between the duplicates was no greater than 15%.
Anti-HIV synergism between sulphated sugars and AZT
To reduce the required doses of drugs and to achieve a higher level of anti-HIV activity, we tested possible synergism between the sulphated sugars and AZT. Remarkable synergism was observed between A-CDS and AZT. In the presence of 0.5 and 1.5fL9 mr' of A-CDS, 10.0nM AZT reduced the virus replication 27.3-and 16.4-fold, respectively, as compared to the 1.2-to 4.9-fold decreases in the presence of either drug individually (Table 3 ). Furthermore, we found that the virus-enhancement effect observed with the low concentration of sulphated sugars was completely abrogated in the combined presence of AZT at 5 and 10nM (data not shown). Anti~HIV synergism between AZT and B-CDS and AZT and PPS was also observed. When combinations of sulphated sugars (not AZl) were tested for anti-HIV activity, the effect seen was neither synergistic nor antagonistic but was of an additive nature (Table 4 ).
Discussion
A-CDS, PPS and B-CDS were found to be potent inhibitors of HIV-1 replication in PMNC cultures. PPS, like OS, has been reported to block the adsorption of HIV-1 on the cells and inhibit RT activity in vitro (Baba et al., 1988; Bagasara and Lischner, 1988; Mitsuya et aI., 1988) . In our experiments PPS but not A-CDS and B-CDS inhibited RT activity in vitro. Further, it has been reported that the anti-RT effect of OS can be obliterated in the presence of serum . Therefore, it is possible that most of the anti-HIV action of A-CDS, PPS and B-CDS may also be associated with virus absorption rather than reverse transcription. Our preliminary studies (not reported) also show that the sulphated sugars are not virucidal but act on the process of virus absorption or post-adsorption on the cells. Nevertheless, it will be interesting to explore further the mechanism of antiviral The interaction between B-CDS and PPS was tested by infecting PHA-PMNCs and exposing to drugs simultaneously. Cell-free culture supernatants were tested using the RT method for virus replication after six days. The decrease in virus replication was calculated on the basis of activity in control drug-free culture. The values represent means of two determinations from two different experiments and the difference between the duplicates was no greater than 15%. A similar additive effect was observed with A-CDS and PPS.
action of A-CDS and B-CDS since they do not inhibit HIV RT activity at the concentrations at which PPS exhibits inhibitory action. The Iymphoproliferative activity of A-CDS, B-CDS and PPS on PMNCs in culture is potentially extremely important in view of the immunosuppression in AIDS patients. Similarly, the protective effect of these drugs on PMNCs from HIV-associated cell death observed in our experiments would be helpful in controlling the immunosuppression. The anti-HIV and Iymphoproliferative activities present in the same chemical compounds have obvious benefits for the control of AIDS.
A transient increase in virus replication observed with PPS and B-CDS (but not with A-CDS) at lower drug concentrations could be due to a combination of factors. First, it could be the result of the spread of infection in the larger number of cells available because of the Iymphoproliferative action of the drugs. Results in Fig. 1 and Table  2 strongly suggest a.correlation between the Iymphoproliferative activity and Virus enhancement by the drugs at low concentrations. For example, A-CDS with low Iymphoproliferative activity is more potent in anti-HIV action and does not show virus enhancement relative to B-CDS and PPS. Virus enhancement could also be due to the direct enhancing effect of the drugs on the RT enzyme. Evidently, this phenomenon of Virus enhancement suggests that such compounds (including OS) could have deleterious effects when used in monotherapy. However, it is encouraging that the virus enhancement effect of sulphated sugars was completely abrogated in the presence of very low amounts (5-10nM) of AZT.
The synergistic interaction between A-CDS and AZT is particularly noteworthy. For example, in the presence of 0.5 f.Lg rnl" of A-CDS, AZT at 10 nM resulted in about a 25-fold decrease in HIV replication in PMNCs relative to the situation when the drugs were used alone. In clinical trials with AZT an effort is usually made to achieve 3 f.LM serum levels which apparently result in toxic doses of AZT (Mitsuya et al., 1987; Richman et al., 1987) . The marked synergism observed between AZT and sulphated sugars may allow the use of AZT at considerably lower concentrations in vivo in combination with A-CDS or PPS, which possess the additional advantage of having Iymphoproliferative activity. In addition, different combinations of sulphated sugars (in the absence of AZT) resulted in additive anti-HIV activity and effects of individual drugs were maintained, suggesting that multiple drug combinations may be achievable. Since A-CDS and B-CDS, unlike PPS, were not inhibitory to RT enzyme, the anti-HIV action of different sulphated sugars, and synergistic action between sulphated sugars and AZT might be the result of multiple mechanisms.
A-CDS, B-CDS and PPS (up to 100 f.Lg rnr') were nontoxic to PMNCs in culture. In addition, PPS given orally has been found to be physiologically active (Thonnard-Neuman and Bigelow, 1988) . Its use for the treatment of interstitial cystitis has been effective and has not resulted in any untoward side-effects (Parson et sl., 1983) . Our studies show that A-CDS is more potent in anti-HIV action than PPS, B-CDS and OS and apparently lacks the virus-enhancement effect. A-CDS has been studied as an agent in the improvement of bioavailability of poorly water-soluble drugs (Pitha et aI., 1988; Pitha, 1989) . lntestinal abortion of A-CDS has been reported in rats (lrie et al., 1988) . Thus, because of the anti-HIV activity, Iymphoproliferative effect, additive effect of A-CDS with PPS and profound synergistic effect of A-CDS with AZT, and their apparent lack of toxicity (in vivo and in vitro), A-C8S could be developed along With AZT into an extremely potent combination chemotherapy for AIDS. Such combination chemotherapy could have dual action which would allow potent anti-HIV activity at lower doses of AZT (lower than shown to be toxic in vivo)and could also help build the immune system as a result of the lymphoproliferative nature of these sulphated sugars.
Materials and Experimental procedures
Cell and viruses
The isolates of HIV-1 used during these studies were U\V-1 S RU (Barre-Sinoussi et al., 1983) , HIV-1 s R (Anand et al., 1989) and HIV-1 45 1 (Devare et al., 1986) . These viruses were grown in human PMNCs and the cell-free virus stocks were frozen below -70°C. Human PMNCs were separated from leukophoresed blood with a Ficoll-Hypaque gradient and stimulated by 10l1og rnr' of phytohaemagglutinin (PHA). After two days, PMNCs were infected and studied for the change in virus replication in the presence of drugs and for the direct effect of drugs on cell multiplication.
Drug treatment
PMNCs stimulated with PHA were further propagated in Medium B (RPMI-1640 with 10% fetal calf serum, 10% T"cell growth factor and 1:500 diluted goat antibody to human interferon). Virus infection and drug treatments were carried out as required for each experiment (see legends to the figure and tables). In general, four hours after infection and drug treatment, cultures were centrifuged to remove the extracellular virus and the cells were resuspended in fresh Medium B and replenished with appropriate drug concentrations. The percent change in virus replication was calculated as (x-c)/c x 100, where x represented the experimental value and c represented the control value. A-CDS and B-CDS, which are cyclic hexa-and heptamers of glucose, respectively, were kindly provided by Dr Josef Pitha (National Institute of Health, Baltimore). The molecular weights of A-CDS and B-CDS are 2400 and 2800, respectively (sodium salt included). PPS(SP-54) and AZT were purchased from Sigma Chemical Co. (St. Louis, MO).
Reverse transcriptase assay
Reverse transcriptase activity was tested by using exogenous templates poly (rA).(dT) with the disrupted virions as described earlier (Anand et al., 1988) . Reduction in RT activity was a reflection of the inhibition of virus production and therefore virus replication. The virus was prepared from the drug-treated and untreated culture supernatants. The reaction mixture was incubated at 37°C for two hours and fH]-TIP incorporated into polymers was precipitated with 10% trichloroacetic acid (TCA) collected on glass fibre (Whatman GF-C) and counted in an LKB 1219 Rackbeta scintillation counter (see legend to Fig. 1 for further details).
Drug toxicity and cell viability
Uninfected PMNCs, drug-treated PMNCs, and drug-treated and virus-infected PMNCs in different experiments were tested for drug toxicity and for the alterations in the numbers of viable cells in response to drug treatment by trypan blue exclusion method.
